--- title: "“cost-effectiveness”: 22 recent papers (last 30 days)" description: "The keyword “cost-effectiveness” appeared in 22 papers in the last 30 days (2026-10-02 to 2026-10-31), ranking #17 of 13,473 keywords." url: https://scholar4ai.com/keywords/cost-effectiveness markdown_url: https://scholar4ai.com/keywords/cost-effectiveness.md license: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/) share_text: "The keyword “cost-effectiveness” appeared in 22 papers in the last 30 days (2026-10-02 to 2026-10-31), ranking #17 of 13,473 keywords." data_url: https://scholar4ai.com/data/rankings.json updated: 2026-10-31T00:01:38+09:00 window: 2026-10-02 to 2026-10-31 source: OpenAlex (CC0) --- # Papers on “cost-effectiveness” - 5 papers in the last 7 days Back to the ranking: https://scholar4ai.com/rankings/keywords.md ## Key findings - The keyword “cost-effectiveness” appeared in 22 papers in the last 30 days (2026-10-02 to 2026-10-31), ranking #17 of 13,473 keywords. - Most of them appeared in Cost Effectiveness and Resource Allocation (8), Applied Health Economics and Health Policy (4) and Health Economics Review (3). - Leading institutions: Griffith University (2), The University of Queensland (2) and Karolinska Institutet (2). - Countries: Australia (4), United Kingdom (4) and United States (3). - Often studied together with “quality-adjusted life years” (7), “incremental cost-effectiveness ratio” (4) and “economic evaluation” (3). ## Research ideas that follow this keyword - [The missing economics of medical AI](https://scholar4ai.com/ideas/the-missing-economics-of-medical-ai.md) *Papers, newest first.* | Date | Title | Journal | Authors | Affiliations | |---|---|---|---|---| | 2026-10-26 | [Economic Evaluation of an E-Dengue Early Warning System for Proactive Dengue Prevention in the Mekong Delta Region, Vietnam: A Protocol](https://doi.org/10.1007/s41669-026-00691-6) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Trinh Manh Hung, Kim-Huong Nguyen, Hugo C. Turner et al. | The University of Queensland; Trinity College Dublin; Imperial College London; … | | 2026-10-26 | [Home-Based Versus Hospital-Based Administration of Enzyme Replacement Therapy for Late-Onset Pompe Disease in Greece: A Cost-Utility and Budget Impact Analysis](https://doi.org/10.1007/s40258-026-01084-w) | [Applied Health Economics and Health Policy](https://scholar4ai.com/journals/applied-health-economics-and-health-policy.md) | Persefoni Kritikou, Gregory F. Guzauskas, Constantinos Papadopoulos et al. | National and Kapodistrian University of Athens; Eginition Hospital | | 2026-10-26 | [Cost-effectiveness of antiviral therapies for hospitalized COVID-19 patients at Dr. Hasan Sadikin Hospital, Indonesia: a retrospective real-world analysis](https://doi.org/10.1186/s12962-026-00847-5) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Cherry Rahayu, Rano Kurnia Sinuraya, Vesara Ardhe Gatera et al. | Padjadjaran University | | 2026-10-26 | [Families caring for children and adolescents with rare disease: a health economic evaluation of face-to-face and online psychosocial support intervention of the randomized controlled CARE-FAM-NET study](https://doi.org/10.1186/s13561-026-00883-0) | [Health Economics Review](https://scholar4ai.com/journals/health-economics-review.md) | Nicolas Pardey, Kristine Kreis, Anna Leidger et al. | Leibniz University Hannover; University Medical Center Hamburg-Eppendorf; University Hospital Ulm; … | | 2026-10-25 | [Measuring the Health of Young Children](https://doi.org/10.1007/s40273-026-01675-4) | [PharmacoEconomics](https://scholar4ai.com/journals/pharmacoeconomics.md) | Daniel M. Hausman | University of Wisconsin–Madison | | 2026-10-24 | [Modelling the potential contributions of polygenic risk stratification to cost-effective screening for prostate cancer](https://doi.org/10.1007/s10198-026-01969-6) | [The European Journal of Health Economics](https://scholar4ai.com/journals/the-european-journal-of-health-economics.md) | Padraig Dixon, Jonathan J. Aning, Richard Michael Martin et al. | University of Oxford; North Bristol NHS Trust; University of Bristol; … | | 2026-10-23 | [A cost-effectiveness analysis of trastuzumab deruxtecan for HER2-low metastatic breast cancer: applying a Saudi economic evaluation guideline](https://doi.org/10.1186/s13561-026-00887-w) | [Health Economics Review](https://scholar4ai.com/journals/health-economics-review.md) | Fatma Maraiki, Tusneem Ahmed M. Elhassan, Shouki N. Bazarbashi et al. | Griffith University; Alfaisal University; King Faisal Specialist Hospital & Research Centre; … | | 2026-10-22 | [Towards meaningful outcome measures for health economic evaluations in skin cancer](https://doi.org/10.1186/s12962-026-00855-5) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Annick Meertens, Lieven Annemans, Floor Verstraete et al. | Ghent University Hospital; Ghent University; Cancer Research Institute Ghent | | 2026-10-20 | [Cost-effectiveness of iStent-based trabecular micro-bypass stenting combined with cataract surgery in mild-to-moderate open-angle glaucoma: a systematic review of analytic perspectives and time horizons](https://doi.org/10.1186/s12962-026-00846-6) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Dan Drobin | Karolinska Institutet | | 2026-10-20 | [Economic evaluation of the Be-Prox anti-bullying intervention in Norwegian early childhood education and care settings: an exploratory partial within-trial cost-effectiveness analysis alongside a cluster randomised controlled trial](https://doi.org/10.1186/s12962-026-00854-6) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Renira C. Angeles, Ingrid Kvestad, Merete Aasheim et al. | NORCE Research AS; UiT The Arctic University of Norway | | 2026-10-20 | [Short-term cost-effectiveness of siltartoxatug versus human tetanus immunoglobulin for post-traumatic tetanus prophylaxis in Chinese adults: a trial-based economic evaluation](https://doi.org/10.1186/s12962-026-00841-x) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Jianrun Zhang, Yuan Xiao, Liwu Huang et al. | First Affiliated Hospital of Guangzhou Medical University; Guangzhou First People's Hospital; South China University of Technology; … | | 2026-10-16 | [Cost Effectiveness of Sertraline for Preventing Domestic Violence Reoffending Among Highly Impulsive Violent Offenders in Australia: A Trial-Based Economic Evaluation](https://doi.org/10.1007/s40258-026-01080-0) | [Applied Health Economics and Health Policy](https://scholar4ai.com/journals/applied-health-economics-and-health-policy.md) | Emaediong Ibong Akpanekpo, Georgina Mary Chambers, Lee Knight et al. | UNSW Sydney; Centre for Big Data Research in Health; Hunter New England Local Health District; … | | 2026-10-15 | [Cost-Effectiveness of Community Health Worker Interventions for Type 2 Diabetes Mellitus: A Systematic Review](https://doi.org/10.1007/s40258-026-01081-z) | [Applied Health Economics and Health Policy](https://scholar4ai.com/journals/applied-health-economics-and-health-policy.md) | Laura R. Porterfield, H. Shelton Brown, Dallin C. Swanson et al. | The University of Texas Medical Branch at Galveston; Stanford Medicine; Baylor College of Medicine | | 2026-10-15 | [Home-based geriatric rehabilitation after shortened inpatient rehabilitation: cost-effectiveness analysis of the “Better@Home” multicentre prospective cohort study with a matched historical control group](https://doi.org/10.1007/s10198-026-02002-6) | [The European Journal of Health Economics](https://scholar4ai.com/journals/the-european-journal-of-health-economics.md) | Chris J. Gamble, Wim G Groen, M. Vaz et al. | Maastricht University; Care and Public Health Research Institute; Amsterdam Public Health; … | | 2026-10-14 | [Cost-effectiveness of virtual reality-based avatar therapy for patients with treatment-resistant schizophrenia](https://doi.org/10.1186/s13561-026-00869-y) | [Health Economics Review](https://scholar4ai.com/journals/health-economics-review.md) | Alexandrina Stoyanova, Raquel Andres, Edit Vass et al. | Universitat de Barcelona; Semmelweis University; Parc Sanitari Sant Joan de Déu; … | | 2026-10-09 | [Methodological Challenges and Preferred Approaches for the Economic Evaluation of CAR T Therapies: Evidence Review and Expert Consensus from NICE Appraisals](https://doi.org/10.1007/s40273-026-01673-6) | [PharmacoEconomics](https://scholar4ai.com/journals/pharmacoeconomics.md) | Mehdi Yousefi, Amin Mehrabian, Maeve A O'Reilly et al. | University of Birmingham; University College Hospital; University of Exeter | | 2026-10-09 | [Cost-Effectiveness of Annual Atrial Fibrillation Screening Compared with Current Opportunistic Screening in Australian Primary Care: A Model-Based Economic Evaluation](https://doi.org/10.1007/s40258-026-01073-z) | [Applied Health Economics and Health Policy](https://scholar4ai.com/journals/applied-health-economics-and-health-policy.md) | Ureni Halahakone, Sameera Jayan Senanayake, Victoria McCreanor et al. | Queensland University of Technology; National University of Singapore; Duke-NUS Medical School; … | | 2026-10-09 | [Influenza disease burden investigation and cost-effectiveness analysis based on system dynamics model](https://doi.org/10.1007/s10198-026-01987-4) | [The European Journal of Health Economics](https://scholar4ai.com/journals/the-european-journal-of-health-economics.md) | Lei Cao, Yu Shao, Zhen Zhang et al. | | | 2026-10-07 | [Cost-effectiveness of maternal Tdap immunisation in Sabah, Malaysia: a historical evaluation of the 2018 birth cohort](https://doi.org/10.1186/s12962-026-00826-w) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Abraham Chiu En Loong, Mohd Yusof Ibrahim, Abdul Rahman Ramdzan et al. | Universiti of Malaysia Sabah; Universitas Pembangunan Nasional Veteran Jakarta | | 2026-10-06 | [Cost-effectiveness of dapagliflozin for the treatment of chronic kidney disease: a systematic review](https://doi.org/10.1186/s12962-026-00817-x) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Zehui Jiang, Nannan Yan, Dongxiao Chen et al. | Jiangxi University of Traditional Chinese Medicine; People's Liberation Army 401 Hospital | | 2026-10-05 | [Cost-effectiveness of early empagliflozin initiation after acute myocardial infarction: a German statutory health insurance perspective](https://doi.org/10.1186/s12962-026-00830-0) | [Cost Effectiveness and Resource Allocation](https://scholar4ai.com/journals/cost-effectiveness-and-resource-allocation.md) | Priyanka Boettger, Eleni S. Nakou, Thomas Kinsley et al. | Justus-Liebig-Universität Gießen; Cardio-Pulmonary Institute; London School of Economics and Political Science; … | | 2026-10-02 | [Cost-Effectiveness Analysis of Ribociclib plus an Aromatase Inhibitor (AI) Versus AI Alone in the Adjuvant Treatment of Stage II and III Pre- and Postmenopausal Women with HR+/HER2− Early Breast Cancer (EBC): A Canadian Payer Perspective](https://doi.org/10.1007/s41669-026-00674-7) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Dina Soliman, Christine Brezden‐Masley, Sandeep R. Sehdev et al. | Novartis (Canada); Mount Sinai Hospital; Ottawa Hospital | ## Cite this page Scholar4AI. (2026). Papers on “cost-effectiveness”. Journal Research Rankings. Retrieved October 31, 2026, from https://scholar4ai.com/keywords/cost-effectiveness ```bibtex @misc{scholar4ai-keywords-cost-effectiveness, author = {{Scholar4AI}}, title = {Papers on “cost-effectiveness”}, year = {2026}, howpublished = {\url{https://scholar4ai.com/keywords/cost-effectiveness}}, urldate = {2026-10-31}, note = {Journal Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0} } ``` License: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/).